Search results
Results from the WOW.Com Content Network
An old and commonly prescribed diabetes medication may help significantly lower the risk of developing long COVID, recently released drug trial data show.. The trial, conducted by a team of ...
In July 2020, the European Medicines Agency (EMA) started reviewing results from the RECOVERY study arm that involved the use of dexamethasone in the treatment of patients with COVID-19 admitted to the hospital to provide an opinion on the results. It focused particularly on the potential use of the drug for the treatment of adults with COVID-19.
[52] [53] [54] As of July 2021, a large number of drugs had been considered for treating COVID-19 patients. [55] As of November 2022, there was moderate-certainty evidence suggesting that dexamethasone, and systemic corticosteroids in general, probably cause a slight reduction in all-cause mortality (up to 30 days) in hospitalized patients with ...
In order to ensure continued access to the pediatric population previously covered under the EUA, the FDA revised the EUA for remdesivir to authorize the drug's use for treatment of suspected or laboratory-confirmed COVID‑19 in hospitalized pediatric patients weighing 3.5 kilograms (7.7 lb) to less than 40 kilograms (88 lb) or hospitalized ...
People who have had COVID-19 are at a greater risk for diabetes, even with Omicron, research finds. Experts explain the correlation between diabetes and COVID.
People may be at increased risk for developing diabetes for up to a year after a diagnosis of COVID-19, according to two studies. One study used data from the U.S. Department of Veterans Affairs ...
Given the risk of morbidity, hospitalization and mortality associated with severe COVID‑19 disease in females and fetuses, nirmatrelvir/ritonavir can provide an important option to reduce the risks associated with acute COVID‑19 infection in at-risk and unvaccinated patients after careful consideration of the benefits and risks for each ...
Veterinary ivermectin, sold alongside an unproven povidone-iodine nasal spray [145] as COVID-19 treatments, at an Amish-run grocery store near McBain, Michigan. In March 2020, then US President Donald Trump promoted the use of chloroquine and hydroxychloroquine, two related anti-malarial drugs, for treating COVID-19. The FDA later clarified ...